This study explores the synthesis, characterization, and biological investigations of two new Pt(II) thiosemicarbazone complexes immobilized in magnetic nanoparticles (MNPs). MNPs exhibit distinctive physical and chemical properties that enhance their interactions with biological targets. These traits make them particularly useful, especially when combined with drugs, increasing therapeutic effectiveness while also serving as efficient diagnostic tools in imaging techniques. The two Pt(II) complexes are represented by the formulas [Pt(HL1)(H2O)]Cl and [Pt(HL2)(H2O)2]Cl. The ligand, H2L1 signifies (Z)-2-(2-oxoindolin-3-ylidene)-N-phenylhydrazine-1-carbothioamide, while H2L2 stands for (Z)-N-ethyl-2-(2-oxoindolin-3-ylidene)hydrazine-1-carbothioamide. The ligands and their Pt(II) complexes were characterized through various techniques, including elemental analysis, mass spectrometry, thermal analysis, powder X-ray diffraction (XRD), FT-IR, NMR, and UV–visible spectroscopy. The two complexes form a square planar geometry, in which H2L1 performs as a mononegative tridentate while H2L2 acts as a mononegative bidentate. Density Functional Theory (DFT) calculations were utilized to investigate the molecular configurations of the ligands and its Pt(II) complexes. The UV–visible and fluorescence spectroscopy techniques were employed to examine the interactions between Pt(II) complexes and Bovine Serum Albumin (BSA). DNA fragmentation studies on the Pt(II) complexes were performed and showed that [Pt(HL2)(H2O)2].Cl complex is the strongest degraded on the DNA. [Pt(HL1)(H2O)]Cl and [Pt(HL2)(H2O)2]Cl complexes were immobilized into MNPs to produce Pt(L1)/MNPs and Pt(L2)/MNPs, respectively. Pt(L1)/MNPs and Pt(L2)/MNPs were identified using FT-IR, PXRD, SEM, TEM, EDX, and UV-spectroscopy. In vitro cytotoxicity tests on these compounds against MCF-7 cell line is applied. Additionally, the antimicrobial activity against two gram + ve bacteria (Bacillus subtilis and staphylococcus aureus), and two gram −ve bacterial strains (Escherichia coli and Salmonella typhi) was investigated. Furthermore, the antioxidant properties (DPPH) of the investigated compounds were assessed. The results of the study indicated that the [Pt(HL2)(H2O)2].Cl complex exhibited a higher biological potency compared to both the [Pt(HL1)(H2O)2].Cl complex and their respective ligands. When Pt(II) complexes were incorporated into the MNPs, a significant increase in their biological activity was noted, especially for Pt(L2)/MNPs, which exhibited the strongest antibacterial and anticancer effects.